ID   Q9HXM5_PSEAE            Unreviewed;       489 AA.
AC   Q9HXM5;
DT   01-MAR-2001, integrated into UniProtKB/TrEMBL.
DT   01-MAR-2001, sequence version 1.
DT   24-JUN-2015, entry version 107.
DE   RecName: Full=Inosine-5'-monophosphate dehydrogenase {ECO:0000256|HAMAP-Rule:MF_01964, ECO:0000256|RuleBase:RU003928};
DE            Short=IMP dehydrogenase {ECO:0000256|HAMAP-Rule:MF_01964};
DE            Short=IMPD {ECO:0000256|HAMAP-Rule:MF_01964};
DE            Short=IMPDH {ECO:0000256|HAMAP-Rule:MF_01964};
DE            EC=1.1.1.205 {ECO:0000256|HAMAP-Rule:MF_01964, ECO:0000256|RuleBase:RU003928};
GN   Name=guaB {ECO:0000256|HAMAP-Rule:MF_01964,
GN   ECO:0000313|EMBL:AAG07157.1};
GN   OrderedLocusNames=PA3770 {ECO:0000313|EMBL:AAG07157.1};
OS   Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG
OS   12228).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964 {ECO:0000313|EMBL:AAG07157.1, ECO:0000313|Proteomes:UP000002438};
RN   [1] {ECO:0000313|EMBL:AAG07157.1, ECO:0000313|Proteomes:UP000002438}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228
RC   {ECO:0000313|Proteomes:UP000002438};
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T.,
RA   Reizer J., Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an
RT   opportunistic pathogen.";
RL   Nature 406:959-964(2000).
RN   [2] {ECO:0000213|PDB:4AVF}
RP   X-RAY CRYSTALLOGRAPHY (2.23 ANGSTROMS).
RX   PubMed=23295481;
RA   Moynie L., Schnell R., McMahon S.A., Sandalova T., Boulkerou W.A.,
RA   Schmidberger J.W., Alphey M., Cukier C., Duthie F., Kopec J., Liu H.,
RA   Jacewicz A., Hunter W.N., Naismith J.H., Schneider G.;
RT   "The AEROPATH project targeting Pseudomonas aeruginosa:
RT   crystallographic studies for assessment of potential targets in early-
RT   stage drug discovery.";
RL   Acta Crystallogr. F 69:25-34(2013).
RN   [3] {ECO:0000213|PDB:3ZFH}
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS).
RX   PubMed=23519796;
RA   Rao V.A., Shepherd S.M., Owen R., Hunter W.N.;
RT   "Structure of Pseudomonas aeruginosa inosine 5'-monophosphate
RT   dehydrogenase.";
RL   Acta Crystallogr. F 69:243-247(2013).
RN   [4] {ECO:0000213|PDB:4DQW}
RP   X-RAY CRYSTALLOGRAPHY (2.51 ANGSTROMS) IN COMPLEX WITH ATP.
RX   PubMed=23643948;
RA   Labesse G., Alexandre T., Vaupre L., Salard-Arnaud I., Him J.L.,
RA   Raynal B., Bron P., Munier-Lehmann H.;
RT   "MgATP regulates allostery and fiber formation in IMPDHs.";
RL   Structure 21:975-985(2013).
CC   -!- FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP)
CC       to xanthosine 5'-phosphate (XMP), the first committed and rate-
CC       limiting step in the de novo synthesis of guanine nucleotides, and
CC       therefore plays an important role in the regulation of cell
CC       growth. {ECO:0000256|HAMAP-Rule:MF_01964}.
CC   -!- CATALYTIC ACTIVITY: Inosine 5'-phosphate + NAD(+) + H(2)O =
CC       xanthosine 5'-phosphate + NADH. {ECO:0000256|HAMAP-Rule:MF_01964,
CC       ECO:0000256|RuleBase:RU003928}.
CC   -!- COFACTOR:
CC       Name=K(+); Xref=ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000256|HAMAP-Rule:MF_01964};
CC   -!- ENZYME REGULATION: Mycophenolic acid (MPA) is a non-competitive
CC       inhibitor that prevents formation of the closed enzyme
CC       conformation by binding to the same site as the amobile flap. In
CC       contrast, mizoribine monophosphate (MZP) is a competitive
CC       inhibitor that induces the closed conformation. MPA is a potent
CC       inhibitor of mammalian IMPDHs but a poor inhibitor of the
CC       bacterial enzymes. MZP is a more potent inhibitor of bacterial
CC       IMPDH. {ECO:0000256|HAMAP-Rule:MF_01964}.
CC   -!- PATHWAY: Purine metabolism; XMP biosynthesis via de novo pathway;
CC       XMP from IMP: step 1/1. {ECO:0000256|HAMAP-Rule:MF_01964,
CC       ECO:0000256|RuleBase:RU003928}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000256|HAMAP-Rule:MF_01964}.
CC   -!- SIMILARITY: Belongs to the IMPDH/GMPR family. {ECO:0000256|HAMAP-
CC       Rule:MF_01964, ECO:0000256|RuleBase:RU003927}.
CC   -!- SIMILARITY: Contains 2 CBS domains. {ECO:0000256|HAMAP-
CC       Rule:MF_01964}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE004091; AAG07157.1; -; Genomic_DNA.
DR   PIR; H83173; H83173.
DR   RefSeq; NP_252459.1; NC_002516.2.
DR   RefSeq; WP_003092702.1; NC_002516.2.
DR   PDB; 3ZFH; X-ray; 2.25 A; A=1-489.
DR   PDB; 4AVF; X-ray; 2.23 A; A/B/C/D=1-489.
DR   PDB; 4DQW; X-ray; 2.51 A; A/B=1-489.
DR   ProteinModelPortal; Q9HXM5; -.
DR   SMR; Q9HXM5; 1-468.
DR   DIP; DIP-60162N; -.
DR   STRING; 208964.PA3770; -.
DR   PRIDE; Q9HXM5; -.
DR   EnsemblBacteria; AAG07157; AAG07157; PA3770.
DR   GeneID; 880535; -.
DR   KEGG; pae:PA3770; -.
DR   PATRIC; 19842179; VBIPseAer58763_3947.
DR   PseudoCAP; PA3770; -.
DR   HOGENOM; HOG000165755; -.
DR   InParanoid; Q9HXM5; -.
DR   KO; K00088; -.
DR   OMA; SSMGYCG; -.
DR   OrthoDB; EOG6GTZPV; -.
DR   PhylomeDB; Q9HXM5; -.
DR   BRENDA; 1.1.1.205; 5087.
DR   UniPathway; UPA00601; UER00295.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003938; F:IMP dehydrogenase activity; IEA:UniProtKB-HAMAP.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0006177; P:GMP biosynthetic process; IEA:UniProtKB-HAMAP.
DR   Gene3D; 3.20.20.70; -; 1.
DR   HAMAP; MF_01964; IMPDH; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR005990; IMP_DH.
DR   InterPro; IPR015875; IMP_DH/GMP_Rdtase_CS.
DR   InterPro; IPR001093; IMP_DH_GMPRt.
DR   Pfam; PF00571; CBS; 2.
DR   Pfam; PF00478; IMPDH; 1.
DR   PIRSF; PIRSF000130; IMPDH; 1.
DR   SMART; SM00116; CBS; 2.
DR   TIGRFAMs; TIGR01302; IMP_dehydrog; 1.
DR   PROSITE; PS51371; CBS; 2.
DR   PROSITE; PS00487; IMP_DH_GMP_RED; 1.
PE   1: Evidence at protein level;
KW   3D-structure {ECO:0000213|PDB:3ZFH, ECO:0000213|PDB:4AVF};
KW   ATP-binding {ECO:0000213|PDB:4DQW};
KW   CBS domain {ECO:0000256|HAMAP-Rule:MF_01964};
KW   Complete proteome {ECO:0000313|Proteomes:UP000002438};
KW   GMP biosynthesis {ECO:0000256|HAMAP-Rule:MF_01964,
KW   ECO:0000256|RuleBase:RU003928};
KW   Metal-binding {ECO:0000256|HAMAP-Rule:MF_01964,
KW   ECO:0000256|RuleBase:RU003928};
KW   NAD {ECO:0000256|HAMAP-Rule:MF_01964, ECO:0000256|RuleBase:RU003928};
KW   Nucleotide-binding {ECO:0000213|PDB:4DQW};
KW   Oxidoreductase {ECO:0000256|HAMAP-Rule:MF_01964,
KW   ECO:0000256|RuleBase:RU003927};
KW   Potassium {ECO:0000256|HAMAP-Rule:MF_01964,
KW   ECO:0000256|RuleBase:RU003928};
KW   Purine biosynthesis {ECO:0000256|HAMAP-Rule:MF_01964,
KW   ECO:0000256|RuleBase:RU003928};
KW   Reference proteome {ECO:0000313|Proteomes:UP000002438};
KW   Repeat {ECO:0000256|HAMAP-Rule:MF_01964}.
FT   DOMAIN       93    148       CBS 1. {ECO:0000256|HAMAP-Rule:MF_01964}.
FT   DOMAIN      152    210       CBS 2. {ECO:0000256|HAMAP-Rule:MF_01964}.
FT   NP_BIND     118    120       ATP. {ECO:0000213|PDB:4DQW}.
FT   NP_BIND     134    137       ATP. {ECO:0000213|PDB:4DQW}.
FT   NP_BIND     180    181       ATP. {ECO:0000213|PDB:4DQW}.
FT   NP_BIND     198    199       ATP. {ECO:0000213|PDB:4DQW}.
FT   NP_BIND     297    299       NAD. {ECO:0000256|HAMAP-Rule:MF_01964}.
FT   REGION      337    339       IMP binding. {ECO:0000256|HAMAP-
FT                                Rule:MF_01964}.
FT   REGION      360    361       IMP binding. {ECO:0000256|HAMAP-
FT                                Rule:MF_01964}.
FT   REGION      384    388       IMP binding. {ECO:0000256|HAMAP-
FT                                Rule:MF_01964}.
FT   ACT_SITE    304    304       Thioimidate intermediate.
FT                                {ECO:0000256|HAMAP-Rule:MF_01964,
FT                                ECO:0000256|PIRSR:PIRSR000130-1}.
FT   METAL       299    299       Potassium; via carbonyl oxygen.
FT                                {ECO:0000256|HAMAP-Rule:MF_01964}.
FT   METAL       301    301       Potassium; via carbonyl oxygen.
FT                                {ECO:0000256|HAMAP-Rule:MF_01964}.
FT   METAL       304    304       Potassium; via carbonyl oxygen.
FT                                {ECO:0000256|HAMAP-Rule:MF_01964}.
FT   METAL       471    471       Potassium; via carbonyl oxygen; shared
FT                                with tetrameric partner.
FT                                {ECO:0000256|HAMAP-Rule:MF_01964}.
FT   METAL       472    472       Potassium; via carbonyl oxygen; shared
FT                                with tetrameric partner.
FT                                {ECO:0000256|HAMAP-Rule:MF_01964}.
FT   METAL       473    473       Potassium; via carbonyl oxygen; shared
FT                                with tetrameric partner.
FT                                {ECO:0000256|HAMAP-Rule:MF_01964}.
FT   BINDING      98     98       ATP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000213|PDB:4DQW}.
FT   BINDING     153    153       ATP. {ECO:0000213|PDB:4DQW}.
FT   BINDING     159    159       ATP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000213|PDB:4DQW}.
FT   BINDING     247    247       NAD. {ECO:0000256|HAMAP-Rule:MF_01964}.
FT   BINDING     302    302       IMP. {ECO:0000256|HAMAP-Rule:MF_01964}.
FT   BINDING     417    417       IMP. {ECO:0000256|HAMAP-Rule:MF_01964}.
SQ   SEQUENCE   489 AA;  51707 MW;  6D2320AFD52C888B CRC64;
     MLRISQEALT FDDVLLIPGY SEVLPKDVSL KTRLTRGIEL NIPLVSAAMD TVTEARLAIA
     MAQEGGIGII HKNMGIEQQA AEVRKVKKHE TAIVRDPVTV TPSTKIIELL QMAREYGFSG
     FPVVEQGELV GIVTGRDLRV KPNAGDTVAA IMTPKDKLVT AREGTPLEEM KAKLYENRIE
     KMLVVDENFY LRGLVTFRDI EKAKTYPLAS KDEQGRLRVG AAVGTGADTG ERVAALVAAG
     VDVVVVDTAH GHSKGVIERV RWVKQTFPDV QVIGGNIATA EAAKALAEAG ADAVKVGIGP
     GSICTTRIVA GVGVPQISAI ANVAAALEGT GVPLIADGGI RFSGDLAKAM VAGAYCVMMG
     SMFAGTEEAP GEIELFQGRS YKSYRGMGSL GAMSGSQGSS DRYFQDASAG AEKLVPEGIE
     GRVPYKGALS AIVHQLMGGL RAAMGYTGSA DIQQMRTQPQ FVRITGAGMA ESHVHDVQIT
     KEAPNYRVG
//
